Farnoush Faridbod
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Farnoush Faridbod has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Reza Ganjali
Center of Excellence in Electrochemistry, School of Chemistry, College of Science, University of Tehran, Tehran, Iran
20 shared publications Parviz Norouzi
University of Tehran
9 shared publicationsMohammad Reza Ganjali
Analytical Chemistry Department, Center of Excellence in Electrochemistry, School of Chemistry, College of Science, University of Tehran, Tehran, Iran; Biosensor Research Center, Endocrinology & Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
7 shared publications- Amin Shiralizadeh Dezfuli
University of Tehran
4 shared publications Hamideh Elmizadeh
4 shared publications- Morteza Hosseini
Nanobiosensors Lab, Department of Nanobiotechnology and Biomimetics, School of Life Science Engineering, College of Interdisciplinary Science and Technology, University of Tehran, Tehran, Iran
4 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 7 (21) , 10869-10880
Detection of miRNA-21 in the early stages of lung and ovarian cancers using a fluorescent biosensor designed through ssDNA binding with a [Ru(bpy) 2 (fmp)](ClO 4 ) 2 complex
An enzyme-free fluorescent biosensor based on an ssDNA–ruthenium complex enables sensitive miR-21 detection through target-induced fluorescence quenching, with successful application to plasma and cancer cell samples.
- 2 November 2026
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 7 (21) , 10869-10880
Open AccessDetection of miRNA-21 in the early stages of lung and ovarian cancers using a fluorescent biosensor designed through ssDNA binding with a [Ru(bpy) 2 (fmp)](ClO 4 ) 2 complex
An enzyme-free fluorescent biosensor based on an ssDNA–ruthenium complex enables sensitive miR-21 detection through target-induced fluorescence quenching, with successful application to plasma and cancer cell samples.
- 30 October 2025
- Published by Springer Nature in Microchimica Acta
- Vol. 192 (11) , 1-18
Simultaneous recognition of two MicroRNAs associated with early stages of lung cancer by DNA hairpin-templated fluorescent nanoclusters
MiRNA-21-5p and miRNA-155-5p have emerged as two promising biomarkers in body fluids during the early stages of lung cancer. This study focused on designing a dual-target optical biosensor for the simultaneous detection of miRNA-21 and miRNA-155. DNA hairpin probes and metal nanoclusters are the materials used in this design. Light-emitting gold nanoclusters (AuNCs) and copper-silver nanoclusters (Cu/AgNCs) were located on hairpin probes to achieve fluorescence-based detection. The biosensor leverages the distinct fluorescence properties of these nanoclusters to detect target miRNAs (miRNA-21 enhances the emission of Cu/AgNCs, while miRNA-155 quenches the emission of AuNCs). The biosensor demonstrated remarkable sensitivity toward miRNA-21 and miRNA-155. Detection limits were 1 pM and 5 pM, and linear response ranges were 15–140 pM and 15–125 pM for miRNA-21 and miRNA-155, respectively. The response of the nanobiosensor was validated by RT-qPCR as the gold standard method in analyses of miRNAs in human serum samples and lung cancer cells. The obtained results confirmed the accuracy and reliability of the biosensor. Compared to existing biosensors, the proposed design avoids complex surface modifications and enzyme usage, ensuring cost-effectiveness and operational simplicity. Graphical abstract
- 30 October 2025
- Published by Springer Nature in Microchimica Acta
- Vol. 192 (11) , 1-18
Simultaneous recognition of two MicroRNAs associated with early stages of lung cancer by DNA hairpin-templated fluorescent nanoclusters
MiRNA-21-5p and miRNA-155-5p have emerged as two promising biomarkers in body fluids during the early stages of lung cancer. This study focused on designing a dual-target optical biosensor for the simultaneous detection of miRNA-21 and miRNA-155. DNA hairpin probes and metal nanoclusters are the materials used in this design. Light-emitting gold nanoclusters (AuNCs) and copper-silver nanoclusters (Cu/AgNCs) were located on hairpin probes to achieve fluorescence-based detection. The biosensor leverages the distinct fluorescence properties of these nanoclusters to detect target miRNAs (miRNA-21 enhances the emission of Cu/AgNCs, while miRNA-155 quenches the emission of AuNCs). The biosensor demonstrated remarkable sensitivity toward miRNA-21 and miRNA-155. Detection limits were 1 pM and 5 pM, and linear response ranges were 15–140 pM and 15–125 pM for miRNA-21 and miRNA-155, respectively. The response of the nanobiosensor was validated by RT-qPCR as the gold standard method in analyses of miRNAs in human serum samples and lung cancer cells. The obtained results confirmed the accuracy and reliability of the biosensor. Compared to existing biosensors, the proposed design avoids complex surface modifications and enzyme usage, ensuring cost-effectiveness and operational simplicity. Graphical abstract
- 6 January 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (1)
Electrocatalytic Effect of Graphitic Carbon Nitride, MWCNTs, and Au Nanoparticle Composite on the Electroanalysis of Sleep Hormone, Melatonin in the Presence of its Precursors in Body Fluids
Electroanalysis of melatonin, known as the sleep hormone, in the presence of its precursors, L‐tryptophan and 5‐hydroxy tryptophan in biological matrixes is an attractive research topic. The interference of voltammetric oxidation signals of these compounds, which have similar chemical structures, causes their determination to be challenging. This project aims to conduct a real‐time electroanalysis of melatonin and its precursors in biological samples using a novel nanocomposite platform. The new platform incorporates multi‐walled carbon nanotubes (MWCNTs), gold nanoparticles (GNPs), and graphitic carbon nitrides (g‐C 3 N 4 ) placed on a glassy carbon electrode surface. The voltammetric oxidation peak of melatonin can be effectively separated from other precursors on this new surface. Thus, melatonin can be easily determined electrochemically in the presence of its precursors. In optimized conditions, this electroanalytical method displayed a linear response range between 5.0 × 10 −7 to 1.0 × 10 −5 mol/L for both melatonin and 5‐hydroxy tryptophan and 5.0 × 10 −8 to 1.0 × 10 −6 mol/L for L‐tryptophan. Furthermore, the proposed modified electrode was successfully applied to determine melatonin and its precursors in various real samples such as human plasma, urine, and pharmaceutical formulations. The new sensor revealed excellent precision, remarkable simplicity, acceptable selectivity, good reproducibility, long‐term stability, and a rapid response toward melatonin, L‐tryptophan, and 5‐hydroxy tryptophan in biological matrixes.
- 6 January 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (1)
Electrocatalytic Effect of Graphitic Carbon Nitride, MWCNTs, and Au Nanoparticle Composite on the Electroanalysis of Sleep Hormone, Melatonin in the Presence of its Precursors in Body Fluids
Electroanalysis of melatonin, known as the sleep hormone, in the presence of its precursors, L‐tryptophan and 5‐hydroxy tryptophan in biological matrixes is an attractive research topic. The interference of voltammetric oxidation signals of these compounds, which have similar chemical structures, causes their determination to be challenging. This project aims to conduct a real‐time electroanalysis of melatonin and its precursors in biological samples using a novel nanocomposite platform. The new platform incorporates multi‐walled carbon nanotubes (MWCNTs), gold nanoparticles (GNPs), and graphitic carbon nitrides (g‐C 3 N 4 ) placed on a glassy carbon electrode surface. The voltammetric oxidation peak of melatonin can be effectively separated from other precursors on this new surface. Thus, melatonin can be easily determined electrochemically in the presence of its precursors. In optimized conditions, this electroanalytical method displayed a linear response range between 5.0 × 10 −7 to 1.0 × 10 −5 mol/L for both melatonin and 5‐hydroxy tryptophan and 5.0 × 10 −8 to 1.0 × 10 −6 mol/L for L‐tryptophan. Furthermore, the proposed modified electrode was successfully applied to determine melatonin and its precursors in various real samples such as human plasma, urine, and pharmaceutical formulations. The new sensor revealed excellent precision, remarkable simplicity, acceptable selectivity, good reproducibility, long‐term stability, and a rapid response toward melatonin, L‐tryptophan, and 5‐hydroxy tryptophan in biological matrixes.
- 23 September 2024
- Published by Elsevier in Optical Materials
- Vol. 157
Analysis of l-Arginine in sports supplements with a colorimetric apta-nanosensor
- 23 September 2024
- Published by Elsevier in Optical Materials
- Vol. 157
Analysis of l-Arginine in sports supplements with a colorimetric apta-nanosensor
- 6 September 2023
- Published by Elsevier in Food Chemistry
- Vol. 434, 137402
Synthesis of polymer dots as fluorescent nanoprobe for the detection of Ponceau 4R, an additive color abuse in food
- 6 September 2023
- Published by Elsevier in Food Chemistry
- Vol. 434, 137402
Synthesis of polymer dots as fluorescent nanoprobe for the detection of Ponceau 4R, an additive color abuse in food
- 26 July 2023
- Published by Springer Nature in Journal of Fluorescence
- Vol. 34 (3) , 1171-1181
Selective and Rapid Optical Detection of Citalopram Using a Fluorescent Probe Based on Carbon Quantum Dots Embedded in Silica Molecularly Imprinted Polymer
In this study, a citalopram optical nano-sensor was developed. Citalopram is a well-known antidepressant drug that reduces the reuptake of serotonin in neurons as a result, serotonin neurotransmission, the primary response to antidepressant treatments, increases in many parts of the brain. This study introduces a carbon quantum dots (CQDs)-based optical nanosensor for rapid detection of citalopram. This fluorescent nanosensor was made through the polymerization of tetraethyl orthosilicate in the presence of CQDs as the fluorescent materials and citalopram as the template molecule. Following the polymerization, the templated molecules were washed and removed from the structure, and the matrix of the polymer was left with some cavities that resembled citalopram in terms of size and shape. The final structure which is used as a chemical nanosensor, is named carbon quantum dots embedded silica molecularly imprinted polymer (CQDs-SMIP). The materials used in designing nano-sensors were characterized using FTIR, UV/Vis, and fluorescence spectroscopy, as well as high-resolution transmission electron microscopy (HR-TEM), and field emission scanning electron microscopy (FESEM). CQDs-SMIP showed a strong fluorescence emission at 420 nm in the absence of the template molecule. The fluorescence intensity of the nanosensor decreased in the presence of citalopram. The correlation between the extent of the fluorescence quenching and the concentration of citalopram provided the nano-sensor signal. The nano-sensor was used to measure citalopram in complex matrices such as human plasma and urine samples with remarkable selectivity and sensitivity. The detection limit of 10.3 µg.L-1 over a linear range of 100 to 700 µg.L-1, and RSD of 3.15% was obtained. This nano-sensor was applied to analyze of citalopram in plasma and human urine samples with remarkable results.
- 26 July 2023
- Published by Springer Nature in Journal of Fluorescence
- Vol. 34 (3) , 1171-1181
Selective and Rapid Optical Detection of Citalopram Using a Fluorescent Probe Based on Carbon Quantum Dots Embedded in Silica Molecularly Imprinted Polymer
In this study, a citalopram optical nano-sensor was developed. Citalopram is a well-known antidepressant drug that reduces the reuptake of serotonin in neurons as a result, serotonin neurotransmission, the primary response to antidepressant treatments, increases in many parts of the brain. This study introduces a carbon quantum dots (CQDs)-based optical nanosensor for rapid detection of citalopram. This fluorescent nanosensor was made through the polymerization of tetraethyl orthosilicate in the presence of CQDs as the fluorescent materials and citalopram as the template molecule. Following the polymerization, the templated molecules were washed and removed from the structure, and the matrix of the polymer was left with some cavities that resembled citalopram in terms of size and shape. The final structure which is used as a chemical nanosensor, is named carbon quantum dots embedded silica molecularly imprinted polymer (CQDs-SMIP). The materials used in designing nano-sensors were characterized using FTIR, UV/Vis, and fluorescence spectroscopy, as well as high-resolution transmission electron microscopy (HR-TEM), and field emission scanning electron microscopy (FESEM). CQDs-SMIP showed a strong fluorescence emission at 420 nm in the absence of the template molecule. The fluorescence intensity of the nanosensor decreased in the presence of citalopram. The correlation between the extent of the fluorescence quenching and the concentration of citalopram provided the nano-sensor signal. The nano-sensor was used to measure citalopram in complex matrices such as human plasma and urine samples with remarkable selectivity and sensitivity. The detection limit of 10.3 µg.L-1 over a linear range of 100 to 700 µg.L-1, and RSD of 3.15% was obtained. This nano-sensor was applied to analyze of citalopram in plasma and human urine samples with remarkable results.
- Open Access
- 18 January 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (1) , e0279816
Carbendazim trace analysis in different samples by using nanostructured modified carbon paste electrode as voltametric sensor
Carbendazim (CBZ) as a fungicide is widely used to control fungal diseases in agriculture, veterinary medicine, and forestry. In this study, molecularly imprinted nano-size polymer was synthesized and then combined with multiwalled carbon nanotubes to be used as modifiers for carbon paste electrode to detect carbendazim in water, fruit, agricultural wastewater, and urine samples by using the square-wave technique. Some common ions and pesticides were investigated as interferences in analyte, to study the sensitivity and selectivity of the modified carbon paste electrode for carbendazim. The combination of molecular imprinted polymer and multiwalled carbon nanotubes showed a significant increase in peak current in electrocatalytic activity on electrochemical detection of the carbendazim. The linear range of 1 × 10−10 to 5 × 10−8 molL−1 was investigated. The lower detection limit was determined to be 0.2 × 10−10 molL−1, and the relative standard deviation for the target molecule analysis was 2.07%. The result reveals that the modified carbon paste sensor with Multi walled Carbon Nanotubes (MWCNTs) and Molecular Imprinted Polymer (MIPs) can be used easily, without preparation steps that have high selectivity and sensitivity to determine carbendazim in water, fruit, agricultural wastewater, and urine samples.
- 18 January 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (1) , e0279816
Open AccessCarbendazim trace analysis in different samples by using nanostructured modified carbon paste electrode as voltametric sensor
Carbendazim (CBZ) as a fungicide is widely used to control fungal diseases in agriculture, veterinary medicine, and forestry. In this study, molecularly imprinted nano-size polymer was synthesized and then combined with multiwalled carbon nanotubes to be used as modifiers for carbon paste electrode to detect carbendazim in water, fruit, agricultural wastewater, and urine samples by using the square-wave technique. Some common ions and pesticides were investigated as interferences in analyte, to study the sensitivity and selectivity of the modified carbon paste electrode for carbendazim. The combination of molecular imprinted polymer and multiwalled carbon nanotubes showed a significant increase in peak current in electrocatalytic activity on electrochemical detection of the carbendazim. The linear range of 1 × 10−10 to 5 × 10−8 molL−1 was investigated. The lower detection limit was determined to be 0.2 × 10−10 molL−1, and the relative standard deviation for the target molecule analysis was 2.07%. The result reveals that the modified carbon paste sensor with Multi walled Carbon Nanotubes (MWCNTs) and Molecular Imprinted Polymer (MIPs) can be used easily, without preparation steps that have high selectivity and sensitivity to determine carbendazim in water, fruit, agricultural wastewater, and urine samples.
- Open Access
- 17 October 2022
- Published by MDPI AG in Biosensors
- Vol. 12 (10) , 879
Earlier Detection of Alzheimer’s Disease Based on a Novel Biomarker cis P-tau by a Label-Free Electrochemical Immunosensor
Early detection of cis phosphorylated tau (cis P-tau) may help as an effective treatment to control the progression of Alzheimer’s disease (AD). Recently, we introduced for the first time a monoclonal antibody (mAb) with high affinity against cis P-tau. In this study, the cis P-tau mAb was utilized to develop a label-free immunosensor. The antibody was immobilized onto a gold electrode and the electrochemical responses to the analyte were acquired by electrochemical impedance spectroscopy (EIS), cyclic voltammetry (CV), and differential pulse voltammetry (DPV). The immunosensor was capable of selective detection of cis P-tau among non-specific targets like trans P-tau and major plasma proteins. A wide concentration range (10 × 10−14 M–3.0 × 10−9 M) of cis P-tau was measured in PBS and human serum matrices with a limit of detection of 0.02 and 0.05 pM, respectively. Clinical applicability of the immunosensor was suggested by its long-term storage stability and successful detection of cis P-tau in real samples of cerebrospinal fluid (CSF) and blood serum collected from human patients at different stages of AD. These results suggest that this simple immunosensor may find great application in clinical settings for early detection of AD which is an unmet urgent need in today’s healthcare services.
- 17 October 2022
- Published by MDPI AG in Biosensors
- Vol. 12 (10) , 879
Open AccessEarlier Detection of Alzheimer’s Disease Based on a Novel Biomarker cis P-tau by a Label-Free Electrochemical Immunosensor
Early detection of cis phosphorylated tau (cis P-tau) may help as an effective treatment to control the progression of Alzheimer’s disease (AD). Recently, we introduced for the first time a monoclonal antibody (mAb) with high affinity against cis P-tau. In this study, the cis P-tau mAb was utilized to develop a label-free immunosensor. The antibody was immobilized onto a gold electrode and the electrochemical responses to the analyte were acquired by electrochemical impedance spectroscopy (EIS), cyclic voltammetry (CV), and differential pulse voltammetry (DPV). The immunosensor was capable of selective detection of cis P-tau among non-specific targets like trans P-tau and major plasma proteins. A wide concentration range (10 × 10−14 M–3.0 × 10−9 M) of cis P-tau was measured in PBS and human serum matrices with a limit of detection of 0.02 and 0.05 pM, respectively. Clinical applicability of the immunosensor was suggested by its long-term storage stability and successful detection of cis P-tau in real samples of cerebrospinal fluid (CSF) and blood serum collected from human patients at different stages of AD. These results suggest that this simple immunosensor may find great application in clinical settings for early detection of AD which is an unmet urgent need in today’s healthcare services.